Log in
Enquire now
EpimAb Biotherapeutics

EpimAb Biotherapeutics

EpimAb Biotherapeutics is a bi-specific Antibodies founded in 2015 by Chengbin Wu.

OverviewStructured DataIssuesContributors

Contents

epimab.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biotechnology
Biotechnology
Engineering
Engineering
Technology
Technology
Biomedical engineering
Biomedical engineering
Biology
Biology
Location
China
China
Shanghai
Shanghai
B2X
B2B
B2B
0
Founder
‌
Chengbin Wu
0
Number of Employees (Ranges)
11 – 500
Email Address
contact@epimab.com
Phone Number
+862161951000
Full Address
6th Floor, Building 2, Jinchuang Building, 702 Zhongke Road, Zhangjiang High-tech Park, Shanghai, 201204, China
Investors
Yanchuang Capital
Yanchuang Capital
Decheng Capital
Decheng Capital
3E Bioventures Capital (3E)
3E Bioventures Capital (3E)
‌
Trend Investment Group
Oriza Seed Venture Capital
Oriza Seed Venture Capital
Founded Date
2015
Total Funding Amount (USD)
99,000,000
Latest Funding Round Date
June 5, 2019
Board of Directors
Victor Tong
Victor Tong
Latest Funding Type
Series B
Series B
Patents Assigned (Count)
2
Country
China
China
Headquarters
Shanghai
Shanghai
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like EpimAb Biotherapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.